A review of the pharmacoeconomics of pharmaceutical care.

摘要: Numerous studies have demonstrated that the therapeutic use of drugs results in adverse outcomes and contributes to high rates morbidity mortality. The causes drug-related problems are multifactorial their assessment has been based on factors such as inappropriate prescribing, delivery, patient behaviour, idiosyncrasy monitoring. cost ambulatory setting estimated exceed total prescription pharmaceutical use. Pharmaceutical care is defined responsible provision drug therapy for purpose achieving definite improve a patient's quality life. It describes process through which pharmacist cooperates with other healthcare professionals designing, implementing monitoring plan will produce specific patient. This article evaluates published related economic analysis enhancing value pharmaceuticals. While numerous descriptive articles exist, our review found no met accepted pharmacoeconomic criteria. A small number measured variables and/or life, but only one considered costs. Barriers optimising were also explored. Common methodological shortcomings indicated need improvement future studies. There little research date demonstrates benefits care. Evidence does exist clinical pharmacy services positive benefits, it this evidence that, at present, supports assertion potential increase pharmaceuticals society by minimising Thus, well conducted required determine impact